Found 24 matching trials
A Study of KRN23 in Subjects With Tumor-Induced Osteomalacia or Epidermal Nevus Syndrome PHASE2 Before switching to the post-marketing study:
To evaluate the efficacy and...
Show More Location
Multiple Locations
Learn More & Join Trial
Long-Term Extension Study of KRN23 in Adult Subjects With X-Linked Hypophosphatemia (XLH) PHASE2 The primary objectives of this study are to:
* Assess the long-term safety...
Show More Location
University California San Francisco Hospital
Learn More & Join Trial
A Study of KRN23 in Pediatric Patients With X-linked Hypophosphatemic Rickets/Osteomalacia PHASE3 Before switching to the post-marketing study:
To evaluate the efficacy and...
Show More Location
Kanagawa Prefectural Hospital Organization Kanagawa Children's Medical Center
Learn More & Join Trial
Study of KRN23 (Burosumab), a Recombinant Fully Human Monoclonal Antibody Against Fibroblast Growth Factor 23 (FGF23), in Pediatric Subjects With X-linked Hypophosphatemia (XLH) PHASE2 The objectives of the study are to:
* Identify a dose and dosing regimen o...
Show More Location
University of California San Francisco
Learn More & Join Trial
X-linked Hypophosphatemia Disease Monitoring Program N/A The objectives of this observational study are to characterize XLH disease ...
Show More Status
Active Not Recruiting
Location
Children's Hospital of Alabama
Learn More & Join Trial
Expanded Access to Burosumab N/A Individual patient expanded access requests may be considered for patients ...
Show More Location
Multiple Locations
Learn More & Join Trial
An Extension Study of KRN23 in Adults With X-Linked Hypophosphatemia PHASE1 The primary purpose of this study is to assess the safety and efficacy of r...
Show More Location
University of California San Francisco
Learn More & Join Trial
Study of KRN23 in Adults With X-linked Hypophosphatemia (XLH) PHASE3 The primary efficacy objective of this study is to establish the effect of ...
Show More Location
Children's Hospital of Los Angeles
Learn More & Join Trial
Study to Assess the Safety, Tolerability, Pharmacokinetics and Efficacy of Burosumab in Patients Less Than 1 Year of Age PHASE1 A Phase 1/2, Open-label, Multicenter, Non-randomized Study to Assess the Sa...
Show More Location
Kepler Universitaetsklinikum GmbH
Learn More & Join Trial
A Repeated Study of KRN23 in Adults With X-Linked Hypophosphatemia PHASE1 The primary purpose of this study is to assess the safety and efficacy of r...
Show More Location
University of California, San Francisco Medical Center
Learn More & Join Trial